ACADEMY CAPITAL MANAGEMENT
Position in PVCT — Provectus Biopharmaceuticals, Inc.
CIK 1031972
WACO, TX
Position in PVCT
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$1,020
-$100 QoQ
Shares Held
20,000
0.0% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PVCT Over Time
Shares Held
Position Value (USD)
All Filings in PVCT
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,020 | 20,000 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,120 | 20,000 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $1,780 | 20,000 | Shares | Sole | 2025-12-12 | |
| 2025-06-30 | $1,500 | 20,000 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $2,000 | 20,000 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,400 | 20,000 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $1,960 | 20,000 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $2,520 | 20,000 | Shares | Sole | 2024-07-30 | |
| 2023-12-31 | $1,920 | 20,000 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,700 | 20,000 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $2,260 | 20,000 | Shares | Sole | 2023-09-07 | |
| 2022-09-30 | $980 | 20,000 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $1,120 | 20,000 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,340 | 20,000 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $1,100 | 20,000 | Shares | Sole | 2022-02-16 | |
| 2021-09-30 | $1,300 | 20,000 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,380 | 20,000 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,360 | 20,000 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,160 | 20,000 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,740 | 20,000 | Shares | Sole | 2020-11-12 | |
| 2020-03-31 | $1,060 | 20,000 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||